Jackie Hunter
Chief Executive Officer
 

Jackie is currently Chief Executive Officer of Benevolent Bio and Director of BenevolentAI, a company that uses AI to augment the research capabilities of drug scientists, radically changing the way R&D is done.  She has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She has served on numerous academic, industry and government Boards and panels in both Europe and is a past CEO of the BBSRC.